Literature DB >> 21461558

Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells.

Yi Zhang1, Xiaoman Xu, Ping He.   

Abstract

Plant materials are a great source of cancer chemotherapeutic agents. Tubeimoside-1 (TBMS1) is a triterpenoid saponin extracted from the tubers of Bolbostemma paniculatum (Maxim.) Franquet (Cucurbitaceae), a widely prescribed traditional Chinese medicinal plant that is used for its antiviral and anti-inflammatory properties. The present study was conducted to investigate the effects of TBMS1 on the growth and apoptosis of human lung cancer A549 cells. TBMS1 inhibited the proliferation of the cells in a dose- and time-dependent manner. Apoptosis was confirmed by flow cytometry, fluorescence microscopy and transmission electron microscopy. TBMS1 treatment induced apoptosis by decreasing the expression of Bcl-2 and increasing the expression of Bax in the A549 cells. Inhibition of COX-2 was also observed after treating the cells with TBMS1. TBMS1 may prove to be a useful approach for the chemotherapy of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21461558     DOI: 10.3892/mmr.2010.379

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  18 in total

1.  Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway.

Authors:  Wenli Hao; Shuai Wang; Zhenli Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway.

Authors:  Quan Bian; Pengfei Liu; Junping Gu; Baoji Song
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Anticancer effect of icaritin on human lung cancer cells through inducing S phase cell cycle arrest and apoptosis.

Authors:  Qian Zheng; Wei-Wei Liu; Bin Li; Hui-Jie Chen; Wen-Shan Zhu; Guang-Xiao Yang; Ming-Jie Chen; Guang-Yuan He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

4.  Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro.

Authors:  Jing-Bo Yang; Muhammad Khan; Yang-Yang He; Min Yao; Yong-Ming Li; Hong-Wen Gao; Tong-Hui Ma
Journal:  Acta Pharmacol Sin       Date:  2016-06-13       Impact factor: 6.150

5.  The first characterization of free radicals formed from cellular COX-catalyzed peroxidation.

Authors:  Yan Gu; Yi Xu; Benedict Law; Steven Y Qian
Journal:  Free Radic Biol Med       Date:  2012-12-20       Impact factor: 7.376

6.  Anticancer Activity of Saponins from Allium chinense against the B16 Melanoma and 4T1 Breast Carcinoma Cell.

Authors:  Zhihui Yu; Tong Zhang; Fengjuan Zhou; Xiuqing Xiao; Xuezhi Ding; Hao He; Jie Rang; Meifang Quan; Ting Wang; Mingxing Zuo; Liqiu Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-03       Impact factor: 2.629

7.  Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway.

Authors:  Geng Jia; Qiang Wang; Rong Wang; Danni Deng; Lian Xue; Naiyuan Shao; Yi Zhang; Xiwei Xia; Feng Zhi; Yilin Yang
Journal:  Onco Targets Ther       Date:  2015-01-30       Impact factor: 4.147

8.  Hepatitis B virus X protein modulates apoptosis in human renal proximal tubular epithelial cells by activating the JAK2/STAT3 signaling pathway.

Authors:  Ping He; Dan Zhang; Hong Li; Xu Yang; Detian Li; Yongzhen Zhai; Li Ma; Guohe Feng
Journal:  Int J Mol Med       Date:  2013-03-07       Impact factor: 4.101

9.  Effects of tubeimoside-1 on the proliferation and apoptosis of BGC823 gastric cancer cells in vitro.

Authors:  Yi Zhang; Xiao-Man Xu; Meng Zhang; Dan Qu; Hui-Yan Niu; Xue Bai; Liang Kan; Ping He
Journal:  Oncol Lett       Date:  2013-01-08       Impact factor: 2.967

10.  Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model.

Authors:  Yuan Gu; Christina Körbel; Claudia Scheuer; Anca Nenicu; Michael D Menger; Matthias W Laschke
Journal:  Oncotarget       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.